Psyence Biomedical (PBM) Interest Expenses (2023 - 2025)

Psyence Biomedical's (PBM) quarterly Interest Expenses came in at -$2753.0 in Q3 2025, down 174.1% year-on-year from $3715.0 in Q3 2024, and down 174.1% quarter-over-quarter from $3715.0 in Q3 2024.

Psyence Biomedical (PBM) Interest Expenses (2023 - 2025) Analysis & Trends

Psyence Biomedical's Interest Expenses history runs 3 years deep, the most recent figure standing at -$2753.0 for Q3 2025.

  • On a quarterly basis, Interest Expenses fell 174.1% year-over-year to -$2753.0 in Q3 2025; TTM through Mar 2026 was $962.0, a 103.97% increase from a year earlier, with the FY2026 full-year figure at $9522.0, up 2.72% from the prior year.
  • Interest Expenses eased to -$2753.0 in Q3 2025 per PBM's latest filing, from $3715.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $3715.0 in Q3 2024 and bottomed at -$27936.0 in Q3 2023.
  • The 3-year median for Interest Expenses is -$2753.0 (2025), against an average of -$8991.3.
  • Across the five-year window, Interest Expenses jumped 113.3% in 2024 and sank 174.1% in 2025, its largest moves.
  • Year by year, Interest Expenses stood at -$27936.0 in 2023, then surged by 113.3% to $3715.0 in 2024, then plunged by 174.1% to -$2753.0 in 2025.
  • Per Business Quant, the three latest PBM Interest Expenses figures stand at -$2753.0 (Q3 2025), $3715.0 (Q3 2024), and -$27936.0 (Q3 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -42,141.15
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 32.89 Mn
4 NuCana 279.75 Bn 279.75 Bn - 16.81 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.17 Bn
10 Psyence Biomedical 1.56 Mn 1.56 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -2,753.00
Sep 30, 2025 -2,753.00
Sep 30, 2024 3,715.00
Sep 30, 2024 3,715.00
Sep 30, 2023 -27,936.00
Sep 30, 2023 -27,936.00